Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade

NCT02244307 · clinicaltrials.gov ↗

COMPLETED

Status

4561

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Hyperplasia

Interventions

DRUG: alpha-adrenergic blocker

Sponsor

Boehringer Ingelheim